London, UK – 22nd August 2022

Patientric is delighted to finally announce the appointment of Sean O’Reilly as its new UK Managing Director.

With over 20 years’ industry experience, Sean has held a number of senior leadership roles across global Pharma and Vaccine companies including GSK, Lundbeck and Valneva. Leading cross-functional teams spanning marketing, sales, medical affairs, supply chain and regulatory affairs, Sean’s last role with Valneva led the launch of its UK commercial business in 2016; playing a leading role in firmly establishing Valneva as a key player within the UK travel vaccine market.

In his various roles within the pharma and vaccines industry, Sean has always held digital innovation as the key to long term success and at the forefront of his vision is investing in ensuring patients have access to the latest vaccines and medicines as easily as possible. Something he will continue to implement in his role as Managing Director of Patientric.

Sean said, “I am delighted to have been appointed as Managing Director of this new and exciting business which is set to disrupt the UK vaccines industry. I will continue to seek out new ways to innovate, create value for service providers and simplify access to vaccines and medicines across the UK; embracing new ground-breaking digital technologies where possible to ensure that consumers and patients have the opportunity to use some of the most advanced vaccines and medicines which may not yet be currently available in the UK on the NHS”.

PAT-CORP-0000006